Lisa Wilson | Investor Relations |
Dane Andreeff | President & Chief Executive Officer |
Jeff Mathiesen | Chief Financial Officer |
Jeffrey Cohen | Ladenburg Thalmann |
Jonathan Aschoff | ROTH Capital Partners |
Good day, and thank you for standing by. Welcome to the Helius Medical Technologies Q3 2022 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to Lisa Wilson, Investor Relations. Please go ahead.